During 2018-2024, there were 3,955 cases of cVDPV polio globally, averaging 565 cases per year. As on September 17, 2025, 143 cVDPV cases have been reported this year. In 2023, five polio cases in east Afghanistan were in children who had received 16 to 28 OPV doses.
Read More
Analyses of data of over 1.2 million children born in Denmark between 1997 and 2018 did not find evidence supporting an increased risk for autoimmune, atopic or allergic, or neurodevelopmental disorders associated with early childhood exposure to aluminium in vaccines
Read More
There is no scientific evidence linking COVID vaccines to sudden deaths. On the contrary, COVID-19 disease itself poses a significant cardiovascular risk, even years after apparent recovery. Studies have shown that those who received COVID vaccine are at lower risk of subsequent cardiovascular events and deaths.
Read More
With a staggering 1.44 million zero-dose children in 2023, and only about nearly reaching the 2019 level of 1.4 million, can India reduce the number of zero-dose children by half of the 2019 level by 2030 to meet the IA2030 target?
Read More
As of March 20, the total number of cases reported across the U.S. stands at 378, with Texas and New
Read More
WHO recommends the influenza strains to be used in the vaccine for the coming flu seasons months in advance based
Read More
While vaccination decreases the severity of acute COVID-19 and the rate of hospitalisation and death, it does not alter the
Read More
This study showed a greater risk reduction than predicted for girls vaccinated at age 12 or 13 years A population-based
Read More
Vaccines are again in acute short supply. As against 10 million doses needed to control the outbreak, just about 0.21
Read More
Cost-effectiveness evidence supports the inclusion of hepatitis A vaccination into the vaccination programme for children aged one year and individuals
Read More
Two other self-controlled case series studies published in July 2020 and January 2021 also did not find Bharat Biotech’s Rotavac
Read More
Of the 600 participants studied, 524 (87.3%) had taken only one dose of the COVID-19 vaccine, while the remaining 76
Read More
If the most glaring limitation of the study is the lack of a control group, the absence of data on
Read More